Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Zenith Health Care Ltd (ZENITHHE) Share Price & Fundamentals

Company Overview

Founded Year

1994

Listed Year

-

Headquarter

Changodar, Gujarat, India

MD/CEO

Mahendra C. Raycha

Website

http://www.zenithhealthcare.com

Company Facts

What we do

Zenith Health Care Ltd manufactures pharmaceutical products including tablets, capsules, ointments, and liquid injectables, providing comprehensive healthcare solutions globally.

Founded in

1,994

Market share

Established player in Indian pharmaceutical manufacturing with integrated facilities and quality certifications enhancing market positioning.

Problem solved

Addresses need for high-quality pharmaceutical formulations and healthcare products, ensuring reliable supply and adherence to quality standards.

Top clients or who we serve

Serves global healthcare providers, pharmaceutical companies, and animal healthcare sectors in B2B model.

Key management

Mahendra C. Raycha (Chairman & Managing Director), Akshit M. Raycha (Joint Managing Director)

Our journey and innovations

Incorporated in 1994 with progressive capacity expansion and ISO & WHO-cGMP certifications, setting benchmarks in product quality and delivery.

Where we operate

Manufacturing in Gujarat, India with global healthcare market presence.

Top products or what we offer

Pharmaceutical tablets, capsules, oral liquids, injectables, and animal healthcare products.

Top brands

-

Raw materials needed

Active pharmaceutical ingredients, excipients for formulations production.

Raw materials supplier

Multiple vendors with forward booking and inventory management practices mitigate commodity price risks.

Recurring vs cyclical contribution

Revenue is mainly recurring through ongoing pharmaceutical product sales and supply contracts.

Our industry position

Mid-sized pharmaceutical manufacturer with strong quality focus and niche in beta-lactam formulations.

Financial highlights

Revenue Rs. 11.33 Crores, net profit Rs. 0.07 Crores for FY 2024-25; slight revenue decline year over year.

Geographical revenue split

-

Order book

-

Whats driving growth

Quality certifications, capacity expansion, technological improvements, and strong supply chain controls driving steady growth.

Our future plans

Focus on enhancing manufacturing capabilities and expanding product portfolio in healthcare segments.

Our green promise

-

Our people and values

Commitment to employee welfare, gender inclusion, and compliance with workplace safety and harassment prevention laws.

Key challenges ahead

Managing raw material price volatility, regulatory compliance, and talent retention amid competitive pressures.

Interesting facts

ISO 9001:2008 & WHO-cGMP certified; integrated production for general and beta-lactam formulations.

Risks and strategy

Risk mitigation through inventory management, compliance audits, talent management, and strategic investment approvals.

Market Footprint

Top Clients

Top Clients

Serves global healthcare providers, pharmaceutical companies, and animal healthcare sectors in B2B model.

Top Products

Top Products

Pharmaceutical tablets, capsules, oral liquids, injectables, and animal healthcare products.

Price Movement & Share Holding

Today's High/Low

3.714.15

52 Week High/Low

2.234.15
Past Returns

1 week

19.54%

1 month

13.52%

3 month

12.81%

1 year

-8.84%

3 year

-9.3%

5 year

-48.06%

Share Holding

Promoters

28.74%

FII

0%

DII

0.39%

Retail

66.02%

Others

4.85%

Company Overview

Founded Year

1994

Listed Year

-

Headquarter

Changodar, Gujarat, India

MD/CEO

Mahendra C. Raycha (Chairman & Managing Director)

Website

http://www.zenithhealthcare.com

Price Movement & Share Holding

Today's High/Low

3.714.15

52 Week High/Low

2.234.15

Past Returns

1 week

19.54%

1 month

13.52%

3 month

12.81%

1 year

-8.84%

3 year

-9.3%

5 year

-48.06%

Share Holding

Promoters

28.74%

FII

0%

DII

0.39%

Retail

66.02%

Others

4.85%

Company Facts

What we do

Zenith Health Care Ltd manufactures pharmaceutical products including tablets, capsules, ointments, and liquid injectables, providing comprehensive healthcare solutions globally.

Founded in

1994

Market share

Established player in Indian pharmaceutical manufacturing with integrated facilities and quality certifications enhancing market positioning.

Problem solved

Addresses need for high-quality pharmaceutical formulations and healthcare products, ensuring reliable supply and adherence to quality standards.

Top clients or who we serve

Serves global healthcare providers, pharmaceutical companies, and animal healthcare sectors in B2B model.

Key management

Mahendra C. Raycha (Chairman & Managing Director), Akshit M. Raycha (Joint Managing Director)

Our journey and innovations

Incorporated in 1994 with progressive capacity expansion and ISO & WHO-cGMP certifications, setting benchmarks in product quality and delivery.

Where we operate

Manufacturing in Gujarat, India with global healthcare market presence.

Top products or what we offer

Pharmaceutical tablets, capsules, oral liquids, injectables, and animal healthcare products.

Raw materials needed

Active pharmaceutical ingredients, excipients for formulations production.

Raw materials supplier

Multiple vendors with forward booking and inventory management practices mitigate commodity price risks.

Recurring vs cyclical contribution

Revenue is mainly recurring through ongoing pharmaceutical product sales and supply contracts.

Our industry position

Mid-sized pharmaceutical manufacturer with strong quality focus and niche in beta-lactam formulations.

Financial highlights

Revenue Rs. 11.33 Crores, net profit Rs. 0.07 Crores for FY 2024-25; slight revenue decline year over year.

Whats driving growth

Quality certifications, capacity expansion, technological improvements, and strong supply chain controls driving steady growth.

Our future plans

Focus on enhancing manufacturing capabilities and expanding product portfolio in healthcare segments.

Our people and values

Commitment to employee welfare, gender inclusion, and compliance with workplace safety and harassment prevention laws.

Key challenges ahead

Managing raw material price volatility, regulatory compliance, and talent retention amid competitive pressures.

Interesting facts

ISO 9001:2008 & WHO-cGMP certified; integrated production for general and beta-lactam formulations.

Risks and strategy

Risk mitigation through inventory management, compliance audits, talent management, and strategic investment approvals.

Market Footprint

Top Clients

Top Clients

Serves global healthcare providers, pharmaceutical companies, and animal healthcare sectors in B2B model.

Top Products

Top Products

Pharmaceutical tablets, capsules, oral liquids, injectables, and animal healthcare products.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions